BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rommasi F, Nasiri MJ, Mirsaeidi M. Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features. Mol Cell Biochem 2022. [PMID: 35013850 DOI: 10.1007/s11010-021-04325-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Isnardi CA, Soriano ER, Graf C, de la Vega MC, Pons-estel BA, Roberts K, Quintana R, Gomez G, Yazdany J, Saurit V, Báez RM, Coello VVC, Pisoni CN, Berbotto G, Vivero F, Zelaya MD, Haye Salinas MJ, Reyes Torres ÁA, Ornella S, Nieto RE, Maldonado FN, Gamba MJ, Severina MDLÁ, Tissera Y, Alba P, Cogo AK, Alle G, Gobbi C, Baños A, Velozo E, Pera M, Tanten R, Albiero JA, Maldonado Ficco H, Martire MV, Elkin MSG, Cosatti M, Cusa MA, Pereira D, Savio VG, Pons-estel GJ. Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry). J Clin Rheumatol 2022;Publish Ahead of Print. [DOI: 10.1097/rhu.0000000000001903] [Reference Citation Analysis]
2 Kiselevskiy MV, Treshalina HM, Mikhailova IN, Martirosyan DV, Manina IV, Reshetnikova VV, Kozlov IG. Opportunities for correction of immunosuppression in patients with COVID-19. Russian Journal of Infection and Immunity 2022;12:651-658. [DOI: 10.15789/2220-7619-ofc-1917] [Reference Citation Analysis]
3 McCarthy MW. Novel Strategies for the Treatment of COVID-19. Drugs R D 2022. [PMID: 35999352 DOI: 10.1007/s40268-022-00400-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]